Back to UBS Group AG UBS Group AG

SNSESNSE
20 quarters

Position history for UBS Group AGUBS Group AG's holdings in FAETH THERAPEUTICS INC

UBS Group AG holds 21,541 shares of SNSE (FAETH THERAPEUTICS INC), worth $538,525 as of 2026-Q2. The position was increased (+375.6% shares). SNSE represents 0.0% of UBS Group AG's portfolio.

Current Value

$538,525

Current Shares

21,541

Total Value Change

+$507,525

Total Shares Change

+19,442

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
21,541
+375.6%
$538,5250.0%$13.85
39
2026-Q1
New
4,529
-
$142,7540.0%$29.00
34
2025-Q4
Exited
0
-100.0%
$00.0%$8.85
0
2025-Q3
Decreased
873
-59.2%
$8,2500.0%$9.55
0
2025-Q2
Decreased
2,140
-95.0%
$18,3610.0%$8.68
0
2025-Q1
Increased
42,541
+21.3Kx
$16,7610.0%$10.16
20
2024-Q4
New
2
-
$10.0%$9.70
17
2024-Q2
Exited
0
-100.0%
$00.0%$12.40
0
2024-Q1
New
139
-
$1460.0%$21.00
17
2023-Q3
Exited
0
-100.0%
$00.0%$16.00
0
2023-Q2
Increased
6,511
+89.3%
$7,4230.0%$26.80
17
2023-Q1
Increased
3,440
+213.6%
$5,1600.0%$27.80
17
2022-Q4
Decreased
1,097
-91.6%
$1,6350.0%$29.80
0
2022-Q3
Decreased
13,114
-2.6%
$20,0000.0%$31.80
0
2022-Q2
Decreased
13,463
-1.1%
$31,0000.0%$44.80
0
2022-Q1
Decreased
13,618
-39.2%
$31,0000.0%$46.60
0
2021-Q4
Increased
22,402
+2120.2%
$130,0000.0%$111.40
24
2021-Q3
Increased
1,009
+45.4%
$11,0000.0%$216.80
16
2021-Q2
Decreased
694
-66.9%
$7,0000.0%$182.00
0
2021-Q1
New
2,099
-
$31,0000.0%$246.00
30

Other major holders of SNSE: Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP, BALYASNY ASSET MANAGEMENT L.P., RA CAPITAL MANAGEMENT, L.P., FRANKLIN RESOURCES INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used